The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santra, S.
Right arrow Articles by Letvin, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santra, S.
Right arrow Articles by Letvin, N. L.
The Journal of Immunology, 2000, 165: 6791-6795.
Copyright © 2000 by The American Association of Immunologists

Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL Responses1

Sampa Santra*, Dan H. Barouch*, Shawn S. Jackson*, Marcelo J. Kuroda*, Joern E. Schmitz*, Michelle A. Lifton*, Arlene H. Sharpe{dagger} and Norman L. Letvin2,*

* Department of Medicine, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and {dagger} Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115

A costimulatory signal in addition to an Ag-specific stimulus is required for optimal activation of T lymphocytes. CD28, the primary positive costimulatory receptor on T cells, has two identified ligands, B7-1 and B7-2. Whether B7-1 and B7-2 have identical, overlapping, or distinct functions remains unresolved. In this study, we show that mice lacking B7-2 were unable to generate CTL responses following immunization with a plasmid DNA vaccine. The ability of these B7-2-deficient mice to generate CTL responses following plasmid gp120 DNA vaccination was fully reconstituted by coadministering either a plasmid expressing B7-2 or B7-1. Moreover, the ability to generate CTL responses following plasmid DNA vaccination in mice lacking both B7-1 and B7-2 could be reconstituted by administering either plasmid B7-1 or plasmid B7-2 with the vaccine construct. These data demonstrate that either B7-1 or B7-2 administered concurrently with a plasmid DNA vaccine can fully costimulate vaccine-elicited CTL responses. Functional differences between B7-1 and B7-2 observed in vivo therefore may not reflect inherent differences in the interactions of CD28 with these ligands.




This article has been cited by other articles:


Home page
J. Virol.Home page
L. G. Thebeau, S. P. Vagvala, Y. M. Wong, and L. A. Morrison
B7 Costimulation Molecules Expressed from the Herpes Simplex Virus 2 Genome Rescue Immune Induction in B7-Deficient Mice
J. Virol., November 15, 2007; 81(22): 12200 - 12209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Takamura, K. Matsuo, Y. Takebe, and Y. Yasutomi
Ag85B of Mycobacteria Elicits Effective CTL Responses through Activation of Robust Th1 Immunity as a Novel Adjuvant in DNA Vaccine
J. Immunol., August 15, 2005; 175(4): 2541 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. S. Jackson, P. Ilyinskii, V. Philippon, L. Gritz, A. G. Yafal, K. Zinnack, K. R. Beaudry, K. H. Manson, M. A. Lifton, M. J. Kuroda, et al.
Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus
J. Virol., May 15, 2005; 79(10): 6554 - 6559.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. W. Peacock, S. K. Nordone, S. S. Jackson, H.-X. Liao, N. L. Letvin, A. G. Yafal, L. Gritz, G. P. Mazzara, B. F. Haynes, and H. F. Staats
Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting
J. Virol., December 1, 2004; 78(23): 13163 - 13172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Agadjanyan, M. A. Chattergoon, M. J. Holterman, B. Monzavi-Karbassi, J. J. Kim, T. Dentchev, D. Wilson, V. Ayyavoo, L. J. Montaner, T. Kieber-Emmons, et al.
Costimulatory Molecule Immune Enhancement in a Plasmid Vaccine Model Is Regulated in Part Through the Ig Constant-Like Domain of CD80/86
J. Immunol., October 15, 2003; 171(8): 4311 - 4319.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
I. K. Srivastava and M. A. Liu
Gene Vaccines
Ann Intern Med, April 1, 2003; 138(7): 550 - 559.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Vasu, A. Wang, S. R. Gorla, S. Kaithamana, B. S. Prabhakar, and M. J. Holterman
CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties
Int. Immunol., February 1, 2003; 15(2): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. H. Barouch, S. Santra, K. Tenner-Racz, P. Racz, M. J. Kuroda, J. E. Schmitz, S. S. Jackson, M. A. Lifton, D. C. Freed, H. C. Perry, et al.
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
J. Immunol., January 15, 2002; 168(2): 562 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.